ENDPOINTS

Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March

Vertex Pharmaceuticals is letting go of 125 employees in Rhode Island after a clinical disappointment for its Phase 1/2 type 1 diabetes program. The Boston-based drugmaker is consolidating three of its buildings ...

Jun 11, 2025 - 02:10
 0
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March
Vertex Pharmaceuticals is letting go of 125 employees in Rhode Island after a clinical disappointment for its Phase 1/2 type 1 diabetes program. The Boston-based drugmaker is consolidating three of its buildings ...
Read More

Tags:

Previous Article

Argenx says its drug Vyvgart looks promising in two more autoimmune diseases

Next Article

Elon Musk’s Political Naivete, Part 376

Related Posts

Analyzing the Endpoints 100; ‘Most favored nation’ targets revealed; Biotech slump makes leases a liability; and more

Analyzing the Endpoints 100; ‘Most favored nation’ targ...

May 24, 2025  0

Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M

Lilly pledges more than $650M to muscle health biotech;...

Jun 11, 2025  0

Startup General Medicine wants to change online shopping for healthcare

Startup General Medicine wants to change online shoppin...

Jun 5, 2025  0